Atezolizumab Trial in Endometrial Cancer - AtTEnd

NCT03603184 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

549

Enrollment

OTHER

Sponsor class

Conditions

Endometrial Cancer

Interventions

DRUG: Atezolizumab
DRUG: Placebos
DRUG: Paclitaxel
DRUG: Carboplatin

Sponsor

Mario Negri Institute for Pharmacological Research

Collaborators

[object Object]